hotspot -WSS

hotspot

author：knowledge 2025-09-27 13:11:11 - browse：23549

A syringe is prepared at a clinic in Norristown, Pa., Dec. 7, 2021. The Environmental Protection Agency finalized a rule Thursday, March 14, 2024, imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes. ( — The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. Matt Rourke/Ap

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities had polluted the air unchecked for decades, leading to disproportionately high cancer risks in surrounding communities.

The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. The rule will require commercial sterilization facilities to monitor and submit proof of their reduced emissions. It aligns with the Biden administration’s greater mission to end cancer and commitment to environmental justice, the EPA said.

Ethylene oxide is the most frequently used sterilizing chemical for devices that can’t be exposed to steam. It’s used to sanitize 20 billion devices in the U.S. per year, such as pacemakers, catheters, and ventilators. But long-term exposure to the gas can cause breast cancer, non-Hodgkin’s lymphoma, lymphocytic leukemia, and myeloma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： A new ‘biological computer' targets cancer while sparing healthy cells

WSS

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

When a patient nears the end, a feared therapy can comfort

Why Novartis is going to walk from its acquisition of MorphoSys

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Readout LOUD: Venture capital, Gilead, and more M&A

The stock market has soared this year, but will it last? Experts weigh in

leisure time

hotspot

explore

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Amgen, Regeneron, BGI Group and more

How one medical school became remarkably diverse

A new ‘biological computer' targets cancer while sparing healthy cells

Novavax promises a turnaround & Lilly roils the obesity market

Why Novartis is going to walk from its acquisition of MorphoSys

Affirmative action in medical school literally saved lives

Mystery swirls around US soldier who entered North Korea days ago, officials say

Novavax promises a turnaround & Lilly roils the obesity market

After a decade, new Gardasil ad campaign gets it (mostly) right

entertainment

A single Democrat is willing to weaken Medicare negotiation power

Judge denies Trump's request for new trial in E. Jean Carroll case

5 dead in mass shooting on Caribbean island of St. Vincent: Police

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Bernie brings in new pharma CEOs to talk drug prices

Unique patient identifier: Experts argue the benefits, pitfalls

entertainment

knowledge

leisure time

leisure time